β-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways

Cytokine

Volumn 23, Issue 3, 2003, Pages 53-63

  Di Marzio, Paola ^a,d   Sherry, Barbara ^a   Thomas, Elaine K ^b   Franchin, Giovanni ^a   Schmidtmayerova, Helena ^a   Bukrinsky, Michael ^a,c  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b AMGEN INC   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d North Shore LIJ Health System   (United States)

Author keywords

CD40L; Macrophages; MAPKs

Indexed keywords

BETA CHEMOKINE; CD40 LIGAND; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C INHIBITOR; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOCOMPETENT CELL; MACROPHAGE; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0042668333     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00186-8     Document Type: Article

References (45)

1. Grewal I.S., Flavell R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev. 153:1996;85-106.
2. Clark L.B., Foy T.M., Noelle R.J. CD40 and its ligand. Adv Immunol. 63:1996;43-78.
3. Tan J., Town T., Mori T., Obregon D., Wu Y., DelleDonne A., et al. CD40 is expressed and functional on neuronal cells. EMBO J. 21:2002;643-652.
4. Castle B.E., Kishimoto K., Stearns C., Brown M.L., Kehry M.R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol. 151:1993;1777-1788.
5. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 365:1993;340-343.
6. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 391:1998;591-594.
7. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu Rev Immunol. 12:1994;881-922.
8. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol. 155:1995;4917-4925.
9. Malik N., Greenfield B.W., Wahl A.F., Kiener P.A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol. 156:1996;3952-3960.
10. Tian L., Noelle R.J., Lawrence D.A. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol. 25:1995;306-309.
11. Stout R.D., Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today. 17:1996;487-492.
12. Cotter R.L., Zheng J., Che M., Niemann D., Liu Y., He J., et al. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J Virol. 75:2001;4308-4320.
13. Di Marzio P., Mariani R., Lui R., Thomas E.K., Landau N.R. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry. Cytokine. 12:2000;1489-1495.
14. Kornbluth R.S., Kee K., Richman D.D. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Natl Acad Sci U S A. 95:1998;5205-5210.
15. + T cells. Science. 270:1995;1811-1815.
16. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
17. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
18. Garzino-Demo A., DeVico A.L., Conant K.E., Gallo R.C. The role of chemokines in human immunodeficiency virus infection. Immunol Rev. 177:2000;79-87.
19. Loetscher P., Moser B., Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol. 74:2000;127-180.
20. Poe J.C., Wagner D.H.J., Miller R.W., Stout R.D., Suttles J. IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis. J Immunol. 159:1997;846-852.
21. Suttles J., Evans M., Miller R.W., Poe J.C., Stout R.D., Wahl L.M. T cell rescue of monocytes from apoptosis: role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity. J Leukoc Biol. 60:1996;651-657.
22. Pearson L.L., Castle B.E., Kehry M.R. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-ssociated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways. Int Immunol. 13:2001;273-283.
23. Suttles J., Milhorn D.M., Miller R.W., Poe J.C., Wahl L.M., Stout R.D. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (IL)-4 and IL-10 anti-inflammatory action. J Biol Chem. 274:1999;5835-5842.
24. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med. 178:1993;669-674.
25. Ho D.D., Rota T.R., Hirsch M.S. Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest. 77:1986;1712-1715.
26. Meltzer M.S., Gendelman H.E. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol. 181:1992;239-263.
27. Salahuddin S.Z., Rose R.M., Groopman J.E., Markham P.D., Gallo R.C. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 68:1986;281-284.
28. Kinter A., Arthos J., Cicala C., Fauci A.S. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol Rev. 177:2000;88-98.
29. Poli G., Biswas P., Fauci A.S. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res. 24:1994;221-233.
30. Chang T.L., Gordon C.J., Roscic-Mrkic B., Power C., Proudfoot A.E., Moore J.P., et al. Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity. J Virol. 76:2002;2245-2254.
31. Kelly M.D., Naif H.M., Adams S.L., Cunningham A.L., Lloyd A.R. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol. 160:1998;3091-3095.
32. Schmidtmayerova H., Sherry B., Bukrinsky M. Chemokines and HIV replication. Nature. 382:1996;767.
33. Han J., Beutler B. The essential role of the UA-rich sequence in endotoxin-induced cachectin/TNF synthesis. Eur Cytokine Netw. 1:1990;71-75.
34. Bailer R.T., Lee B., Montaner L.J. IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur J Immunol. 30:2000;1340-1349.
35. Lane B.R., Markovitz D.M., Woodford N.L., Rochford R., Strieter R.M., Coffey M.J. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing CC chemokine receptor 5 (CCR5) expression. J Immunol. 163:1999;3653-3661.
36. Diehl L., den Boer A.T., Schoenberger S.P., van d V., Schumacher T.N., Melief C.J., et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med. 5:1999;774-779.
37. Schoenberger S.P., Toes R.E., van d V., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:1998;480-483.
38. Sacca R., Cuff C.A., Ruddle N.H. Mediators of inflammation. Curr Opin Immunol. 9:1997;851-857.
39. Hacker H., Vabulas R.M., Takeuchi O., Hoshino K., Akira S., Wagner H. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6. J Exp Med. 192:2000;595-600.
40. Chow C.W., Demaurex N., Grinstein S. Ion transport and the function of phagocytic cells. Curr Opin Hematol. 2:1995;89-95.
41. Hart P.H., Bonder C.S., Balogh J., Dickensheets H.L., Donnelly R.P., Finlay-Jones J.J. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol. 66:1999;575-578.
42. Moreland L.W., Baumgartner S.W., Schiff M.H., Tindall E.A., Fleischmann R.M., Weaver A.L., et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 337:1997;141-147.
43. Franchin G., Zybarth G., Dai W.W., Dubrovsky L., Reiling N., Schmidtmayerova H., et al. Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J Immunol. 164:2000;2592-2601.
44. Di Marzio P., Tse J., Landau N.R. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses. 14:1998;129-138.
45. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol. 69:1995;7909-7916.